The most unkindest cut of all: On the multiple roles of mammalian caspases

Leukemia

Volumn 14, Issue 8, 2000, Pages 1514-1525

  Fadeel, B ^a   Orrenius, S ^a   Zhivotovsky, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Caspase; Chemotherapy; Fas; Inflammation; Leukemia

Indexed keywords

CASPASE; CASPASE INHIBITOR; CELL PROTEIN; CYSTEINE PROTEINASE;

ANIMAL CELL; APOPTOSIS; CELL ACTIVATION; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME INHIBITION; ERYTHROPOIESIS; HUMAN; HUMAN CELL; INFLAMMATION; LENS FIBER; LEUKEMIA CELL; LYMPHOCYTE PROLIFERATION; MAMMAL; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL; T LYMPHOCYTE;

EID: 0033908043     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401871     Document Type: Review

References (167)

1. Cell death: The significance of apoptosis
2. Apoptosis in human disease: a new skin for the old ceremony?
3. The hallmarks of
4. Andrew Wyllie: From left field to center stage
5. Caspase structure, proteolytic subtrates, and function during apoptotic cell death
6. Death by design: Mechanism and control of apoptosis
7. Caspase activation: The induced-proximity model
8. Biochemical pathways of caspase activation during apoptosis
9. Molecular characterization of mitochondrial apoptosis-inducing factor
10. Caspase-3 is required for cleavage of α-fodrin but dispensible for cleavage of other death substrates in apoptosis
11. A cellular poison cupboard
12. Caspase-independent programmed cell death with necrotic morphology
13. BAX-induced cell death may not require interleukin 1 β-converting enzyme-like proteases
14. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways
15. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis
16. Intracellular ATP levels determine cell death fate by apoptosis or necrosis
17. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes
18. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia
19. Apoptosis: Cell death defined by caspase activation
20. Involvement of cellular proteolytic machinery in apoptosis
21. Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain subtrates
22. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation
23. Implication of calpain in caspase activation during B cell clonal deletion
24. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases
25. Caspase-dependent activation of calpain during drug-induced apoptosis
26. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis
27. Cleavage of the calpain inhibitor, calpastatin, during apoptosis
28. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: Inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity
29. Cathepsin D protease mediates programmed cell death by interferon-gamma, Fas/APO-1 and TNF-alpha
30. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity
31. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity
32. Disassembly of genome of higher eukaryotes: Pulse-field gel electrophoretic study of initial stages of chromatin and DNA degradation in rat liver and thymus nuclei by VM-26 and selected proteases
33. Calcium-dependent, interleukin-1 β-converting enzyme inhibitor-insensitive degradation of lamin B1 and DNA fragmentation in isolated thymocyte nuclei
34. Two differrent proteases are involved in the proteolysis of lamin during apoptosis
35. Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes
36. Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes
37. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes
38. Mice deficient in IL-1β converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock
39. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme
40. CPP32/apopain is a key interleukin-1β converting enzyme-like protease involved in Fas-mediated killing
41. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE
42. Processing and activation of pro-interleukin-16 by caspase-3
43. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes
44. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1
45. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor
46. Fas antigen signals proliferation of normal human diploid fibroblasts and its mechanism is different from tumor necrosis factor receptor
47. Fas transduces activation signals in normal human T lymphocytes
48. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression
49. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids
50. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation
51. Activation of caspase-3-like enzymes in non-apoptotic T cells
52. Granzyme release and caspase activation in activated human T-lymphocytes
53. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells
54. Caspase activation is required for T cell proliferation
55. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
56. FAP-1: A protein tyrosine phosphatase that associates with Fas
57. Down-regulation of FAS-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells
58. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases
59. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1
60. A role for caspases in lens fiber differentiation
61. Possible involvement of caspase-like family in maintenance of cytoskeleton integrity
62. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
63. Easpases: Enemies within
64. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
65. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
66. Differential requirement for caspase 9 in apoptotic pathways in vivo
67. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
68. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo-1, and DR3 and is lethal prenatally
69. Apaf-1 (CED-4 homolog) regulates programmed cell death in mammalian development
70. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
71. Death by a thousand cuts: An ever increasing list of caspase subtrates
72. Caspase-mediated proteolysis during apoptosis: Insights from apoptotic neutrophils
73. Proteolytic specificity of caspases is required to signal the appearance of apoptotic morphology
74. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
75. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation
76. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of Bcl-2 modulation or dependence on functional p53
77. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis
78. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction
79. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
80. Drug-induced apoptosis in hepatoma cells is mediated by by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
81. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
82. 2-Chloro-2'-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4
83. Selection for drug resistance results in resistance to Fas-mediated apoptosis
84. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)
85. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions
86. Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-indepedent way
87. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
88. Myeloma cells selected for resistance to CD95-mediated apoptosos are not cross-resistant to cytotoxic drugs: Evidence for independent mechanisms of caspase activation
89. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic cells
90. The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice
91. The tyrosine kinase Lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation
92. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery
93. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
94. Regulation of cell death protease caspase-9 by phosphorylation
95. Caspase phophorylation, cell death, and species variability
96. Caspase phosphorylation, cell death, and species variability. Response
97. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
98. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogene domains (PODs)
99. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis
100. Emerging from the Pak: The p21-activated protein kinase family
101. p21-Activated kinase 1 phosphorylates the death agonist Bad and protects cells from apoptosis
102. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2
103. An essential role for NF-kB in preventing TNFα-induced cell death
104. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis
105. Activation of a pro-apoptotic amplification loop through inhibition of NF-kB-dependent survival signals by caspase-mediated inactivation of RIP
106. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kB loop
107. Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription
108. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B-cells
109. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
110. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
111. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c
112. DΦskeland SO. Injected cytochrome c induces apoptosis
113. Apoptotic cytosol facilitates Bax transcription to mitochondria that involves cytosolic factor regulated by Bcl-2
114. Conversion of bcl-2 to a bax-like death effector by caspases
115. Modulation of cell death by BCl-X(L) through caspase interaction
116. Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells
117. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c
118. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells
119. All along the watchtower: On the regulation of apoptosis regulators
120. Human homologue of S. pombe Rad9 interacts with Bcl-2/Bcl-(X)(L) and promotes apoptosis
121. Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis
122. Characterization of the interleukin-1β-converting enzyme/Ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease. Lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease
123. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes
124. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlation with in vitro and in vivo chemoresponses
125. The CARD domain: A new signalling motif
126. Inactivating mutations and overexpression of BCI-10, caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)
127. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma amd mutated in multiple tumor types
128. Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kB activation
129. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells
130. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
131. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via hydrogen peroxide-dependent pathway
132. Mechanism of dithiocarbamate inhibition of apoptosis: Thiol oxidation by dithiocarbamate disulfides directly inhibits processing of the caspase-3 proenzyme
133. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis
134. Drug-induced apoptosis in chronic lymphocytic leukemia
135. Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia
136. Cancer gene therapy using a pro-apoptotic gene, caspase-3
137. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors
138. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis
139. The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling
140. Detection of pro-caspase-3 in cytosol and mitochondria of various tissues
141. Mitochondrial release of caspase-2 and -9 during the apoptotic process
142. Caspases: Their intracellular localization and translocation during apoptosis
143. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
144. Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: A novel mechanism of nuclear apoptosis resistance
145. Defective caspase-3 relocalization in non-small cell lung carcinoma: Mechanism for a nuclear apoptosis resistance
146. Induction of mitochondrial permeability transition and cytochrome c release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells
147. Loss of the Fanconi anemia group C protein activity results in an ability to activate caspase-3 after ionizing radiation
148. Processing/activation of caspases-3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells
149. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma
150. Caspase inhibitors
151. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death
152. Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors
153. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
154. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
155. BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins
156. IAP family proteins - suppressors of apoptosis
157. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
158. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
159. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma
160. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
161. Control of apoptosis and mitotic spindle checkpoint by survivin
162. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
163. Cell division regulation by BIR1, a member of the inhibitor of apoptosis family in yeast
164. Survivin-δEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitors survivin with different properties
165. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions
166. Apoptosis and cancer drug targeting
167. Blood cells with reduced mithochondrial membrane potential and cytosolic cytochrome c can survive and maintain clonogenicity given appropriate signals to suppress apoptosis